126 материалов по теме, собраны автоматически из проверенных источников
Immune cells can reach head and neck tumors, but once there, many stop functioning. This helps explain why immunotherapy with immune checkpoint inhibitors—which have transformed treatment for some cancers—benefits only 17%–23% of patients with head and neck squamous cell carcinoma. These are cancers that arise from…
Omega fatty acids have long been recognized for their benefits: supporting cardiovascular health, reducing systemic inflammation, and promoting brain development and cognitive function. But scientists now warn of a long-unrecognized downside to these compounds when it comes to cancer and immunotherapy.
A Blood Test Could Identify Targets for Personalized Immunotherapy American Association for Cancer Research (AACR)
Enhancing CAR-T Therapy: From Cancer to Autoimmune Diseases | Newswise Newswise
Link Cell Therapies Begins Phase I Trial of Logic-Gated CAR-T Therapy for Kidney Cancer BioPharma APAC
Link Cell Therapies Begins Phase I Trial of Logic-Gated CAR-T Therapy for Kidney Cancer BioPharma APAC
KEYNOTE-A18 and INTERLACE: Immunotherapy and Treatment Intensification in Cervical Cancer Oncodaily
In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.
Link Cell Therapies Initiates Clinical Dosing with Logic-Gated CAR-T Therapy, Expands Executive Leadership, and Upsizes Series A Financing to $90 Mill us.acrofan.com
Link Cell Therapies Initiates Clinical Dosing with Logic-Gated CAR-T Therapy, Expands Executive Leadership, and Upsizes Series A Financing to $90 Million StreetInsider
Ученые обнаружили опасную уязвимость после иммунотерапии рака Наука Mail
Immuno 2026 Day 3 Highlights: Cancer Vaccines, Local Immunotherapy and the Patient Perspective Oncodaily
Immuno 2026 Day 2 Highlights: Unraveling the Tumor Microenvironment and New Paths to Overcome Immunotherapy Resistance Oncodaily
Immuno 2026 Opens with Global Leaders Exploring the Next Decade of Cancer Immunotherapy Oncodaily
When Hugo Aerts, PhD, started asking colleagues whether the thymus could play a role in determining which patients with cancer would respond to immunotherapy about 4 years ago, the responses were overwhelmingly dismissive. “It’s irrelevant,” they told him. “[The thymus is] important in kids. Afterwards, it doesn’t…